How many clinical approvals and trials has AIM Vaccine completed by Dec 2023?

Question

Accepted Answer

AIM Vaccine Achieved 14 Clinical Approvals and Conducted 21 Clinical Trials by the End of 2023

As of December 31, 2023, AIM Vaccine had secured a total of 14 clinical approvals and successfully conducted 21 clinical trials. Among these, five vaccine varieties had progressed to the final stage of Phase III clinical trials, with the construction of their respective production workshops substantially completed and preparations for market launch underway. The company has outlined plans for 2024 to submit market applications for three products and initiate clinical applications for seven additional products.
Pneumonia and Rabies Vaccine Development Progressed

Significant milestones were reached in the development of pneumonia and rabies vaccines. The full course of vaccination for the 13-valent pneumonia conjugate vaccine (PCV13) Phase III clinical trial was completed, and a pre-application for marketing registration was submitted to the NMPA. Similarly, the Phase III clinical trial subjects for the 23-valent pneumonia polysaccharide vaccine (PPSV23) and the iterative serum-free rabies vaccine completed their full vaccination courses.
Global Innovative Vaccines Advanced

AIM Vaccine also made strides in developing globally innovative vaccines. The EV71-CA16 bivalent HFMD vaccine, a world-first development, obtained clinical approvals. Furthermore, the iterative mRNA rabies vaccine was accepted by relevant authorities in China as the first non-COVID-19 mRNA vaccine candidate.
Robust Investment in Research and Development

The company demonstrated a sustained high level of investment in research and development throughout 2023, with R&D expenses reaching RMB 636.4 million. This figure represents a 27.2% increase compared to the previous year, and R&D expenditure constituted 53.6% of revenue, underscoring AIM Vaccine's commitment to innovation and its position at the forefront of the industry.

Reading history

Hide →

This history is cleared when the page is closed.

How many clinical approvals and trials has AIM Vaccine completed by Dec 2023?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends